Gastrointestinal (GI) disorders include functional bowel diseases such as irritable bowel syndrome (IBS) and inflammatory bowel diseases such as Crohn's disease (CD) and colitis. Some gastrointestinal drug can control or moderate the symptoms of gastrointestinal disorders. Scope of the Report: This report focuses on the Gastrointestinal Drug in Global market, especially in North America, Europe and Asia-Pacific, South America, Middle East and Africa. This report categorizes the market based on manufacturers, regions, type and application. Market Segment by Manufacturers, this report covers AstraZenec Sanofi Bayer Pfizer GlaxoSmithKline Teva Zeria?Tillotts? Perrigo Boehringer Ingelheim Purdue Pharma C.B. Fleet Abbott Jiangzhong Xian-Janssen Market Segment by Regions, regional analysis covers North America (USA, Canada and Mexico) Europe (Germany, France, UK, Russia and Italy) Asia-Pacific (China, Japan, Korea, India and Southeast Asia) South America (Brazil, Argentina, Columbia etc.) Middle East and Africa (Saudi Arabia, UAE, Egypt, Nigeria and South Africa) Market Segment by Type, covers Prescription Gastrointestinal Drug OTC Gastrointestinal Drug Market Segment by Applications, can be divided into Chronic Gastritis Functional Dyspepsia Peptic Ulcer Acute Gastroenteritis There are 15 Chapters to deeply display the global Gastrointestinal Drug market. Chapter 1, to describe Gastrointestinal Drug Introduction, product scope, market overview, market opportunities, market risk, market driving force; Chapter 2, to analyze the top manufacturers of Gastrointestinal Drug, with sales, revenue, and price of Gastrointestinal Drug, in 2016 and 2017; Chapter 3, to display the competitive situation among the top manufacturers, with sales, revenue and market share in 2016 and 2017; Chapter 4, to show the global market by regions, with sales, revenue and market share of Gastrointestinal Drug, for each region, from 2012 to 2017; Chapter 5, 6, 7, 8 and 9, to analyze the key regions, with sales, revenue and market share by key countries in these regions; Chapter 10 and 11, to show the market by type and application, with sales market share and growth rate by type, application, from 2012 to 2017; Chapter 12, Gastrointestinal Drug market forecast, by regions, type and application, with sales and revenue, from 2017 to 2022; Chapter 13, 14 and 15, to describe Gastrointestinal Drug sales channel, distributors, traders, dealers, Research Findings and Conclusion, appendix and data source
Table of Contents 1 Market Overview 1.1 Gastrointestinal Drug Introduction 1.2 Market Analysis by Type 1.2.1 Prescription Gastrointestinal Drug 1.2.2 OTC Gastrointestinal Drug 1.3 Market Analysis by Applications 1.3.1 Chronic Gastritis 1.3.2 Functional Dyspepsia 1.3.3 Peptic Ulcer 1.3.4 Acute Gastroenteritis 1.4 Market A
